APA
Conconi A., Martinelli G., Lopez-Guillermo A., Zinzani P. L., Ferreri A. J. M., Rigacci L., Devizzi L., Vitolo U., Luminari S., Cavalli F. & Zucca E. (20110614). Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani P L, Ferreri A J M, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F and Zucca E. 20110614. Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Conconi A., Martinelli G., Lopez-Guillermo A., Zinzani P. L., Ferreri A. J. M., Rigacci L., Devizzi L., Vitolo U., Luminari S., Cavalli F. and Zucca E. (20110614). Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani P L, Ferreri A J M, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F and Zucca E. Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). : Annals of oncology : official journal of the European Society for Medical Oncology. 20110614.